A randomized control trial between fosfomycin and cefuroxime as the antibiotic prophylaxis in knee arthroplasty.
暂无分享,去创建一个
[1] P. Choong,et al. Microbiological Aetiology, Epidemiology, and Clinical Profile of Prosthetic Joint Infections: Are Current Antibiotic Prophylaxis Guidelines Effective? , 2012, Antimicrobial Agents and Chemotherapy.
[2] M. Falagas,et al. Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. , 2012, The Journal of antimicrobial chemotherapy.
[3] Gwo-Chin Lee,et al. Does Dual Antibiotic Prophylaxis Better Prevent Surgical Site Infections in Total Joint Arthroplasty? , 2012, Clinical orthopaedics and related research.
[4] A. Michalopoulos,et al. The revival of fosfomycin. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[5] L. Lidgren,et al. Timing of preoperative antibiotics for knee arthroplasties: Improving the routines in Sweden , 2011, Patient safety in surgery.
[6] K. Kaye,et al. Revisiting “Older” Antimicrobials in the Era of Multidrug Resistance , 2011, Pharmacotherapy.
[7] E. Lambiris,et al. Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and two specific antistaphylococcal agents. , 2010, The Journal of arthroplasty.
[8] A. Lombardi,et al. Minimizing Infection Risk: Fortune Favors the Prepared Mind , 2010 .
[9] L. Lidgren,et al. Inadequate timing of prophylactic antibiotics in orthopedic surgery. We can do better , 2009, Acta orthopaedica.
[10] Hien H. Nguyen,et al. Prophylactic antibiotics in hip and knee arthroplasty. , 2009, The Journal of bone and joint surgery. American volume.
[11] A. Hutchinson,et al. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. , 2008, The Journal of bone and joint surgery. British volume.
[12] K. Fung,et al. Infection in primary total knee replacement. , 2008, Hong Kong medical journal = Xianggang yi xue za zhi.
[13] A. Rosenstein,et al. Infection prevention in total knee and total hip arthroplasties. , 2008, American journal of orthopedics.
[14] Gwo-Chin Lee,et al. Case report: cefazolin-induced hemolytic anemia. , 2007, Clinical orthopaedics and related research.
[15] A. Apisarnthanarak,et al. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[16] Ken‐ichiro Yoshida,et al. Randomized prospective comparison of fosfomycin and cefotiam for prevention of postoperative infection following urological surgery , 2007, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[17] T. Pieber,et al. Second-line Treatment of Limb-Threatening Diabetic Foot Infections with Intravenous Fosfomycin , 2005, Journal of chemotherapy.
[18] R. Spencer,et al. C reactive protein and skin temperature post total knee replacement. , 2005, The Knee.
[19] D. Fry,et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. , 2005, Archives of surgery.
[20] R. Rahmanzadeh,et al. Adjuvant fosfomycin medication in chronic osteomyelitis , 1989, Infection.
[21] K. Oungbho,et al. The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system. , 2004, Clinical orthopaedics and related research.
[22] G. Bannister,et al. Infection after total knee arthroplasty. , 2004, The Journal of bone and joint surgery. British volume.
[23] A. Hanssen. Prophylactic use of antibiotic bone cement: an emerging standard--in opposition. , 2004, The Journal of arthroplasty.
[24] S. Hughes,et al. Cefuroxime in CMW bone cement , 1985, International Orthopaedics.
[25] D. Nadal,et al. Fosfomycin for the initial treatment of acute haematogenous osteomyelitis , 2003, Archives of disease in childhood.
[26] O. Bajolet,et al. Postoperative Spondylodiskitis due to Stomatococcus mucilaginosus in an Immunocompetent Patient , 2003, Scandinavian journal of infectious diseases.
[27] W. Lo,et al. Cefuroxime-Impregnated Cement in Primary Total Knee Arthroplasty: A Prospective, Randomized Study of Three Hundred and Forty Knees , 2002, The Journal of bone and joint surgery. American volume.
[28] R. Viola,et al. Postoperative Infections Following Total Knee Replacement: An Epidemiological Study , 2001, Journal of chemotherapy.
[29] F. Lalla. Antibiotic prophylaxis in orthopedic prosthetic surgery. , 2001 .
[30] A. Baldini,et al. [Risk factors and prevention of infections of hip and knee prostheses]. , 2000, Journal of chemotherapy.
[31] B. Allaouchiche,et al. [Diffusion in bone tissue of antibiotics]. , 1999, Presse medicale.
[32] K. Lewis. Audit of timing of antibiotic prophylaxis in hip and knee arthroplasty. , 1998, Journal of the Royal College of Surgeons of Edinburgh.
[33] G. Maclellan,et al. Postoperative changes of erythrocyte sedimentation rate, plasma viscosity and C-reactive protein levels after hip surgery. , 1998, Acta orthopaedica Belgica.
[34] S. Stern,et al. Diagnosis and management of the infected total knee arthroplasty. , 1996, The American journal of knee surgery.
[35] V. Hernández Casado. Fosfomycin in a traumatological department. , 1977, Chemotherapy.